Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Immune Check Point Inhibitors Market Size Growth Rate by Type (2014-2025) 1.4.2 CLTA-4 Inhibitors 1.4.3 PD-1 & PD-L1 Inhibitor 1.5 Market by Application 1.5.1 Global Immune Check Point Inhibitors Market Share by Application (2014-2025) 1.5.2 Lung Cancer 1.5.3 Blood Cancer 1.5.4 Renal Cancer 1.5.5 Bladder Cancer 1.5.6 Melanoma 1.5.7 Hodgkin Lymphoma 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Immune Check Point Inhibitors Market Size 2.2 Immune Check Point Inhibitors Growth Trends by Regions 2.2.1 Immune Check Point Inhibitors Market Size by Regions (2014-2025) 2.2.2 Immune Check Point Inhibitors Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Immune Check Point Inhibitors Market Size by Manufacturers 3.1.1 Global Immune Check Point Inhibitors Revenue by Manufacturers (2014-2019) 3.1.2 Global Immune Check Point Inhibitors Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Immune Check Point Inhibitors Market Concentration Ratio (CR5 and HHI) 3.2 Immune Check Point Inhibitors Key Players Head office and Area Served 3.3 Key Players Immune Check Point Inhibitors Product/Solution/Service 3.4 Date of Enter into Immune Check Point Inhibitors Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Immune Check Point Inhibitors Market Size by Type (2014-2019) 4.2 Global Immune Check Point Inhibitors Market Size by Application (2014-2019) 5 United States 5.1 United States Immune Check Point Inhibitors Market Size (2014-2019) 5.2 Immune Check Point Inhibitors Key Players in United States 5.3 United States Immune Check Point Inhibitors Market Size by Type 5.4 United States Immune Check Point Inhibitors Market Size by Application 6 Europe 6.1 Europe Immune Check Point Inhibitors Market Size (2014-2019) 6.2 Immune Check Point Inhibitors Key Players in Europe 6.3 Europe Immune Check Point Inhibitors Market Size by Type 6.4 Europe Immune Check Point Inhibitors Market Size by Application 7 China 7.1 China Immune Check Point Inhibitors Market Size (2014-2019) 7.2 Immune Check Point Inhibitors Key Players in China 7.3 China Immune Check Point Inhibitors Market Size by Type 7.4 China Immune Check Point Inhibitors Market Size by Application 8 Japan 8.1 Japan Immune Check Point Inhibitors Market Size (2014-2019) 8.2 Immune Check Point Inhibitors Key Players in Japan 8.3 Japan Immune Check Point Inhibitors Market Size by Type 8.4 Japan Immune Check Point Inhibitors Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Immune Check Point Inhibitors Market Size (2014-2019) 9.2 Immune Check Point Inhibitors Key Players in Southeast Asia 9.3 Southeast Asia Immune Check Point Inhibitors Market Size by Type 9.4 Southeast Asia Immune Check Point Inhibitors Market Size by Application 10 India 10.1 India Immune Check Point Inhibitors Market Size (2014-2019) 10.2 Immune Check Point Inhibitors Key Players in India 10.3 India Immune Check Point Inhibitors Market Size by Type 10.4 India Immune Check Point Inhibitors Market Size by Application 11 Central & South America 11.1 Central & South America Immune Check Point Inhibitors Market Size (2014-2019) 11.2 Immune Check Point Inhibitors Key Players in Central & South America 11.3 Central & South America Immune Check Point Inhibitors Market Size by Type 11.4 Central & South America Immune Check Point Inhibitors Market Size by Application 12 International Players Profiles 12.1 Bristol-Myers Squibb Company 12.1.1 Bristol-Myers Squibb Company Company Details 12.1.2 Company Description and Business Overview 12.1.3 Immune Check Point Inhibitors Introduction 12.1.4 Bristol-Myers Squibb Company Revenue in Immune Check Point Inhibitors Business (2014-2019) 12.1.5 Bristol-Myers Squibb Company Recent Development 12.2 AstraZeneca plc 12.2.1 AstraZeneca plc Company Details 12.2.2 Company Description and Business Overview 12.2.3 Immune Check Point Inhibitors Introduction 12.2.4 AstraZeneca plc Revenue in Immune Check Point Inhibitors Business (2014-2019) 12.2.5 AstraZeneca plc Recent Development 12.3 Merck & Co 12.3.1 Merck & Co Company Details 12.3.2 Company Description and Business Overview 12.3.3 Immune Check Point Inhibitors Introduction 12.3.4 Merck & Co Revenue in Immune Check Point Inhibitors Business (2014-2019) 12.3.5 Merck & Co Recent Development 12.4 Pfizer, Inc 12.4.1 Pfizer, Inc Company Details 12.4.2 Company Description and Business Overview 12.4.3 Immune Check Point Inhibitors Introduction 12.4.4 Pfizer, Inc Revenue in Immune Check Point Inhibitors Business (2014-2019) 12.4.5 Pfizer, Inc Recent Development 12.5 F. Hoffmann-La Roche Ltd 12.5.1 F. Hoffmann-La Roche Ltd Company Details 12.5.2 Company Description and Business Overview 12.5.3 Immune Check Point Inhibitors Introduction 12.5.4 F. Hoffmann-La Roche Ltd Revenue in Immune Check Point Inhibitors Business (2014-2019) 12.5.5 F. Hoffmann-La Roche Ltd Recent Development 12.6 Incyte Corporation 12.6.1 Incyte Corporation Company Details 12.6.2 Company Description and Business Overview 12.6.3 Immune Check Point Inhibitors Introduction 12.6.4 Incyte Corporation Revenue in Immune Check Point Inhibitors Business (2014-2019) 12.6.5 Incyte Corporation Recent Development 12.7 NewLink Genetics Corporation 12.7.1 NewLink Genetics Corporation Company Details 12.7.2 Company Description and Business Overview 12.7.3 Immune Check Point Inhibitors Introduction 12.7.4 NewLink Genetics Corporation Revenue in Immune Check Point Inhibitors Business (2014-2019) 12.7.5 NewLink Genetics Corporation Recent Development 12.8 Celldex Therapeutics, Inc 12.8.1 Celldex Therapeutics, Inc Company Details 12.8.2 Company Description and Business Overview 12.8.3 Immune Check Point Inhibitors Introduction 12.8.4 Celldex Therapeutics, Inc Revenue in Immune Check Point Inhibitors Business (2014-2019) 12.8.5 Celldex Therapeutics, Inc Recent Development 12.9 GlaxoSmithKline plc 12.9.1 GlaxoSmithKline plc Company Details 12.9.2 Company Description and Business Overview 12.9.3 Immune Check Point Inhibitors Introduction 12.9.4 GlaxoSmithKline plc Revenue in Immune Check Point Inhibitors Business (2014-2019) 12.9.5 GlaxoSmithKline plc Recent Development 12.10 Seattle Genetics, Inc. 12.10.1 Seattle Genetics, Inc. Company Details 12.10.2 Company Description and Business Overview 12.10.3 Immune Check Point Inhibitors Introduction 12.10.4 Seattle Genetics, Inc. Revenue in Immune Check Point Inhibitors Business (2014-2019) 12.10.5 Seattle Genetics, Inc. Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Immune Check Point Inhibitors Key Market Segments Table Key Players Immune Check Point Inhibitors Covered Table Global Immune Check Point Inhibitors Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Immune Check Point Inhibitors Market Size Market Share by Type 2014-2025 Figure CLTA-4 Inhibitors Figures Table Key Players of CLTA-4 Inhibitors Figure PD-1 & PD-L1 Inhibitor Figures Table Key Players of PD-1 & PD-L1 Inhibitor Table Global Immune Check Point Inhibitors Market Size Growth by Application 2014-2025 (Million US$) Figure Lung Cancer Case Studies Figure Blood Cancer Case Studies Figure Renal Cancer Case Studies Figure Bladder Cancer Case Studies Figure Melanoma Case Studies Figure Hodgkin Lymphoma Case Studies Figure Immune Check Point Inhibitors Report Years Considered Table Global Immune Check Point Inhibitors Market Size 2014-2025 (Million US$) Figure Global Immune Check Point Inhibitors Market Size and Growth Rate 2014-2025 (Million US$) Table Global Immune Check Point Inhibitors Market Size by Regions 2014-2025 (Million US$) Table Global Immune Check Point Inhibitors Market Size by Regions 2014-2019 (Million US$) Table Global Immune Check Point Inhibitors Market Share by Regions 2014-2019 Figure Global Immune Check Point Inhibitors Market Share by Regions 2014-2019 Figure Global Immune Check Point Inhibitors Market Share by Regions 2019 Table Market Top Trends Table Global Immune Check Point Inhibitors Revenue by Manufacturers (2014-2019) (Million US$) Table Global Immune Check Point Inhibitors Market Share by Manufacturers (2014-2019) Figure Global Immune Check Point Inhibitors Market Share by Manufacturers in 2018 Table Global Immune Check Point Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Immune Check Point Inhibitors Product/Solution/Service Table Date of Enter into Immune Check Point Inhibitors Market Table Mergers & Acquisitions, Expansion Plans Table Global Immune Check Point Inhibitors Market Size by Type (2014-2019) (Million US$) Table Global Immune Check Point Inhibitors Market Size Share by Type (2014-2019) Figure Global Immune Check Point Inhibitors Market Size Market Share by Type (2014-2019) Table Global Immune Check Point Inhibitors Market Size by Application (2014-2019) (Million US$) Table Global Immune Check Point Inhibitors Market Size Share by Application (2014-2019) Figure Global Immune Check Point Inhibitors Market Size Market Share by Application (2014-2019) Figure Global Immune Check Point Inhibitors Revenue Market Share by Application in 2018 Figure United States Immune Check Point Inhibitors Market Size 2014-2019 (Million US$) Table United States Key Players Immune Check Point Inhibitors Revenue (2018-2019) (Million US$) Table United States Key Players Immune Check Point Inhibitors Market Share (2018-2019) Table United States Immune Check Point Inhibitors Market Size by Type (2014-2019) (Million US$) Table United States Immune Check Point Inhibitors Market Share by Type (2014-2019) Table United States Immune Check Point Inhibitors Market Size by Application (2014-2019) (Million US$) Table United States Immune Check Point Inhibitors Market Share by Application (2014-2019) Figure Europe Immune Check Point Inhibitors Market Size 2014-2019 (Million US$) Table Europe Key Players Immune Check Point Inhibitors Revenue (2018-2019) (Million US$) Table Europe Key Players Immune Check Point Inhibitors Market Share (2018-2019) Table Europe Immune Check Point Inhibitors Market Size by Type (2014-2019) (Million US$) Table Europe Immune Check Point Inhibitors Market Share by Type (2014-2019) Table Europe Immune Check Point Inhibitors Market Size by Application (2014-2019) (Million US$) Table Europe Immune Check Point Inhibitors Market Share by Application (2014-2019) Figure China Immune Check Point Inhibitors Market Size 2014-2019 (Million US$) Table China Key Players Immune Check Point Inhibitors Revenue (2018-2019) (Million US$) Table China Key Players Immune Check Point Inhibitors Market Share (2018-2019) Table China Immune Check Point Inhibitors Market Size by Type (2014-20189) (Million US$) Table China Immune Check Point Inhibitors Market Share by Type (2014-2019) Table China Immune Check Point Inhibitors Market Size by Application (2014-2019) (Million US$) Table China Immune Check Point Inhibitors Market Share by Application (2014-2019) Figure Japan Immune Check Point Inhibitors Market Size 2014-2019 (Million US$) Table Japan Key Players Immune Check Point Inhibitors Revenue (2018-2019) (Million US$) Table Japan Key Players Immune Check Point Inhibitors Market Share (2018-2019) Table Japan Immune Check Point Inhibitors Market Size by Type (2014-2019) (Million US$) Table Japan Immune Check Point Inhibitors Market Share by Type (2014-2019) Table Japan Immune Check Point Inhibitors Market Size by Application (2014-2019) (Million US$) Table Japan Immune Check Point Inhibitors Market Share by Application (2014-2019) Figure Southeast Asia Immune Check Point Inhibitors Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Immune Check Point Inhibitors Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Immune Check Point Inhibitors Market Share (2018-2019) Table Southeast Asia Immune Check Point Inhibitors Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Immune Check Point Inhibitors Market Share by Type (2014-2019) Table Southeast Asia Immune Check Point Inhibitors Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Immune Check Point Inhibitors Market Share by Application (2014-2019) Figure India Immune Check Point Inhibitors Market Size 2014-2019 (Million US$) Table India Key Players Immune Check Point Inhibitors Revenue (2018-2019) (Million US$) Table India Key Players Immune Check Point Inhibitors Market Share (2018-2019) Table India Immune Check Point Inhibitors Market Size by Type (2014-2019) (Million US$) Table India Immune Check Point Inhibitors Market Share by Type (2014-2019) Table India Immune Check Point Inhibitors Market Size by Application (2014-2019) (Million US$) Table India Immune Check Point Inhibitors Market Share by Application (2014-2019) Figure Central & South America Immune Check Point Inhibitors Market Size 2014-2019 (Million US$) Table Central & South America Key Players Immune Check Point Inhibitors Revenue (2018-2019) (Million US$) Table Central & South America Key Players Immune Check Point Inhibitors Market Share (2018-2019) Table Central & South America Immune Check Point Inhibitors Market Size by Type (2014-2019) (Million US$) Table Central & South America Immune Check Point Inhibitors Market Share by Type (2014-2019) Table Central & South America Immune Check Point Inhibitors Market Size by Application (2014-2019) (Million US$) Table Central & South America Immune Check Point Inhibitors Market Share by Application (2014-2019) Table Bristol-Myers Squibb Company Company Details Table Bristol-Myers Squibb Company Revenue in Immune Check Point Inhibitors Business (2014-2019) (Million US$) Figure Bristol-Myers Squibb Company Revenue Growth Rate in Immune Check Point Inhibitors Business (2014-2019) Table Bristol-Myers Squibb Company Recent Development Table AstraZeneca plc Company Details Table AstraZeneca plc Revenue in Immune Check Point Inhibitors Business (2014-2019)(Million US$) Figure AstraZeneca plc Revenue Growth Rate in Immune Check Point Inhibitors Business (2014-2019) Table AstraZeneca plc Recent Development Table Merck & Co Company Details Table Merck & Co Revenue in Immune Check Point Inhibitors Business (2014-2019)(Million US$) Figure Merck & Co Revenue Growth Rate in Immune Check Point Inhibitors Business (2014-2019) Table Merck & Co Recent Development Table Pfizer, Inc Company Details Table Pfizer, Inc Revenue in Immune Check Point Inhibitors Business (2014-2019)(Million US$) Figure Pfizer, Inc Revenue Growth Rate in Immune Check Point Inhibitors Business (2014-2019) Table Pfizer, Inc Recent Development Table F. Hoffmann-La Roche Ltd Company Details Table F. Hoffmann-La Roche Ltd Revenue in Immune Check Point Inhibitors Business (2014-2019)(Million US$) Figure F. Hoffmann-La Roche Ltd Revenue Growth Rate in Immune Check Point Inhibitors Business (2014-2019) Table F. Hoffmann-La Roche Ltd Recent Development Table Incyte Corporation Company Details Table Incyte Corporation Revenue in Immune Check Point Inhibitors Business (2014-2019)(Million US$) Figure Incyte Corporation Revenue Growth Rate in Immune Check Point Inhibitors Business (2014-2019) Table Incyte Corporation Recent Development Table NewLink Genetics Corporation Company Details Table NewLink Genetics Corporation Revenue in Immune Check Point Inhibitors Business (2014-2019)(Million US$) Figure NewLink Genetics Corporation Revenue Growth Rate in Immune Check Point Inhibitors Business (2014-2019) Table NewLink Genetics Corporation Recent Development Table Celldex Therapeutics, Inc Company Details Table Celldex Therapeutics, Inc Revenue in Immune Check Point Inhibitors Business (2014-2019)(Million US$) Figure Celldex Therapeutics, Inc Revenue Growth Rate in Immune Check Point Inhibitors Business (2014-2019) Table Celldex Therapeutics, Inc Recent Development Table GlaxoSmithKline plc Company Details Table GlaxoSmithKline plc Revenue in Immune Check Point Inhibitors Business (2014-2019)(Million US$) Figure GlaxoSmithKline plc Revenue Growth Rate in Immune Check Point Inhibitors Business (2014-2019) Table GlaxoSmithKline plc Recent Development Table Seattle Genetics, Inc. Company Details Table Seattle Genetics, Inc. Revenue in Immune Check Point Inhibitors Business (2014-2019)(Million US$) Figure Seattle Genetics, Inc. Revenue Growth Rate in Immune Check Point Inhibitors Business (2014-2019) Table Seattle Genetics, Inc. Recent Development Table Global Immune Check Point Inhibitors Market Size by Regions (Million US$) 2019-2025 Figure Global Immune Check Point Inhibitors Market Size Share by Regions (2019-2025) Figure Global Immune Check Point Inhibitors Market Size Share by Regions in 2025 Figure United States Immune Check Point Inhibitors Market Size Forecast (2019-2025)(Million USD) Figure Europe Immune Check Point Inhibitors Market Size Forecast (2019-2025)(Million USD) Figure China Immune Check Point Inhibitors Market Size Forecast (2019-2025)(Million USD) Figure Japan Immune Check Point Inhibitors Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Immune Check Point Inhibitors Market Size Forecast (2019-2025)(Million USD) Figure India Immune Check Point Inhibitors Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Immune Check Point Inhibitors Market Size Forecast (2019-2025)(Million USD) Table Global Immune Check Point Inhibitors Market Size by Product (2019-2025) (Million US$) Figure Global Immune Check Point Inhibitors Market Size by Product (2019-2025) Figure Global Immune Check Point Inhibitors Market Size by Product in 2025 Table Global Immune Check Point Inhibitors Market Size by Application (2019-2025) (Million US$) Figure Global Immune Check Point Inhibitors Market Size by Application (2019-2025) Figure Global Immune Check Point Inhibitors Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Bristol-Myers Squibb Company AstraZeneca plc Merck & Co Pfizer, Inc F. Hoffmann-La Roche Ltd Incyte Corporation NewLink Genetics Corporation Celldex Therapeutics, Inc GlaxoSmithKline plc Seattle Genetics, Inc.